BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 5, 2026
Home
»
Topics
»
Disease categories and therapies
» Urology
Urology
RSS
Action Pharma presents data from phase II trial of AP-214
Nov. 29, 2011
In vitro and clinical data presented on Vitae Pharmaceuticals' renin inhibitor
Nov. 28, 2011
Phase III study investigates phosphate-lowering effects of SBR-759
Nov. 25, 2011
Astellas Pharma prepares novel NPT-IIb inhibitors
Nov. 24, 2011
Merck & Co. designs novel beta3-adrenoceptor agonists
Nov. 23, 2011
KAI Pharmaceuticals releases clinical data on KAI-4169
Nov. 23, 2011
Early clinical studies of CTP-499 conducted in healthy subjects
Nov. 21, 2011
PBI-4050 demonstrates nephroprotection in animal models
Nov. 16, 2011
FX-06 may be beneficial for renal transplant
Nov. 16, 2011
FDA and EMA accept Astellas' submissions for mirabegron
Nov. 15, 2011
Previous
1
2
…
103
104
105
106
107
108
109
110
111
…
318
319
Next
RSS